Resultat av tuberkulosebehandling i Norge 1995
DOI:
https://doi.org/10.5324/nje.v7i2.412Sammendrag
SAMMENDRAG
I tillegg til insidens og mortalitet, har andelen pasienter som fullfører tuberkulosebehandlingen («helbredelsesrate
») nylig blitt anbefalt av IUATLD og WHO som en indikator for vurdering av tuberkulosekontrollen.
I denne studien ble resultatet av tuberkulosebehandlingen vurdert hos alle pasienter med dyrkningsbekreftet
lungetuberkulose meldt til Det sentrale tuberkuloseregister i 1995. Av 101 pasienter fullførte 77 behandlingen
(«helbredelsesrate» 76%), 9 forsvant, 14 døde og én fortsatte å være smitteførende. De fleste (7 av 9)
som forsvant var født utenfor Norge, mens de fleste (13 av 14) som døde var født i Norge.
Helbredelsesraten i Norge er langt dårligere enn WHOs anbefalinger (85% helbredelsesrate) og resultatene
oppnådd i enkelte andre land som Nederland. Vurdering av behandlingsresultat er en viktig del av
tuberkuloseovervåkningen. Tiltak bør iverksettes for å redusere mortaliteten og andelen pasienter som
forsvinner før avsluttet behandling.
Heldal E.
Results of tuberculosis treatment in Norway 1995. Nor J Epidemiol 1997; 7 (2): 231-233.
ENGLISH SUMMARY
In addition to incidence and mortality the proportion of patients who complete tuberculosis treatment (cure
rate) has recently been recommended by the IUATLD and WHO as an indicator in assessing tuberculosis
control. In the present study the result of tuberculosis treatment was assessed in all patients with culture
confirmed pulmonary tuberculosis notified to the National Tuberculosis Register in 1995. Out of 101
patients 77 completed treatment (cure rate 76%), 9 disappeared, 14 died and one continued to be contagious
(failure case). Most of those who disappeared (7 out of 9) were born outside Norway, while most of those
who died (13 out of 14) were born in Norway.
The cure rate in Norway was far below the level of 85% recommended by WHO, and achieved in
countries like the Netherlands. The assessment of treatment result is an important component of tuberculosis
surveillance. Action should be taken to reduce mortality and the proportion of patients who disappear from
treatment.
I
NNLEDNING
Downloads
Nedlastinger
Publisert
Hvordan referere
Utgave
Seksjon
Lisens
Norsk Epidemiologi licenses all content of the journal under a Creative Commons Attribution (CC-BY) licence. This means, among other things, that anyone is free to copy and distribute the content, as long as they give proper credit to the author(s) and the journal. For further information, see Creative Commons website for human readable or lawyer readable versions.
Authors who publish with this journal agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
